Eagle Asset Management Inc Takeda Pharmaceutical CO LTD Transaction History

Eagle Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$13.36 - $15.43 $20,694 - $23,901	-1,549 Reduced 4.28%	34,664 $494,000
Q3 2023 Nov 13, 2023	SELL	$15.03 - $16.32 $15,616 - $16,956	-1,039 Reduced 2.79%	36,213 $560,000
Q2 2023 Aug 09, 2023	SELL	$15.57 - $17.11 $21,517 - $23,646	-1,382 Reduced 3.58%	37,252 $585,000
Q1 2023 May 08, 2023	BUY	$15.28 - $16.48 $25,043 - $27,010	1,639 Added 4.43%	38,634 $636,000
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $459,477 - $577,861	36,995 New	36,995 $577,000

341

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.8B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.